Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma–a case report

Acta Oncologica

Volumn 56, Issue 8, 2017, Pages 1126-1131

  Falk, Hanne ^a   Lambaa, Susanne ^a   Johannesen, Helle Hjorth ^a   Wooler, Gitte ^a   Venzo, Alessandro ^a   Gehl, Julie ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BLEOMYCIN; TEMOZOLOMIDE; CALCIUM;

AGED; ANALGESIA; BIOPSY; BRAIN METASTASIS; CALCIUM ELECTROPORATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CHRONIC INFLAMMATION; COMORBIDITY; DRUG WITHDRAWAL; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION; INGUINAL LYMPH NODE; IRRADIATION; LETTER; LOWER LIMB METASTASIS; LUNG EMBOLISM; LYMPHADENOPATHY; MELANOMA; METASTASIS; MITOSIS; MUTATION; NEUROENDOCRINE TUMOR; NUMERIC RATING SCALE; PAIN; PANCYTOPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; RETREATMENT; SKIN DEFECT; SKIN METASTASIS; SURGICAL MARGIN; THROMBUS; UTERUS TUMOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; ADAPTIVE IMMUNITY; DRUG EFFECT; IMMUNOLOGY; PATHOLOGY; PROCEDURES; REMISSION; SKIN TUMOR; TUMOR ESCAPE;

ADAPTIVE IMMUNITY; AGED, 80 AND OVER; CALCIUM; ELECTROCHEMOTHERAPY; ELECTROPORATION; FEMALE; HUMANS; MELANOMA; NEOPLASM METASTASIS; REMISSION INDUCTION; SKIN NEOPLASMS; TUMOR ESCAPE;

EID: 85013372007     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/0284186X.2017.1290274     Document Type: Letter

References (26)

1. Campana LG, Valpione S, Mocellin S, et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg. 2012;99:821–830.
2. Heller R, Jaroszeski MJ, Reintgen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148–157.
3. Kis E, Olah J, Ocsai H, et al. Electrochemotherapy of cutaneous metastases of melanoma—a case series study and systematic review of the evidence. Dermatol Surg. 2011;37:816–824.
4. Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy–an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases:results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006;4:3–13.
5. Matthiessen LW, Chalmers RL, Sainsbury DC, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011;50:621–629.
6. Matthiessen LW, Johannesen HH, Hendel HW, et al. Electrochemotherapy for large cutaneous recurrence of breast cancer:a phase II clinical trial. Acta Oncol. 2012;51:713–721.
7. Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer:a meta-analysis. J Clin Oncol. 2014;32:3144–3155.
8. Calvet CY, Famin D, Andre FM, et al. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology. 2014;3:e28131.
9. Mir LM, Roth C, Orlowski S, et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol. 1995;17:30–38.
10. Mir LM, Orlowski S, Poddevin B, et al. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw. 1992;3:331–334.
11. Sersa G, Cemazar M, Menart V, et al. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett. 1997;116:85–92.
12. Andersen MH, Gehl J, Reker S, et al. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol. 2003;13:449–459.
13. Byrne CM, Thompson JF, Johnston H, et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res. 2005;15:45–51.
14. Quaglino P, Mortera C, Osella-Abate S, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol. 2008;15:2215–2222.
15. Heppt MV, Eigentler TK, Kahler KC, et al. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma:a retrospective multicenter analysis. Cancer Immunol Immunother. 2016;65:951–959.
16. Mozzillo N, Simeone E, Benedetto L, et al. Assessing a novel immuno-oncology-based combination therapy:ipilimumab plus electrochemotherapy. Oncoimmunology. 2015;4:e1008842.
17. Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy:instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. EJC Suppl. 2006;4:14–25.
18. Kalialis LV, Drzewiecki KT, Klyver H., Spontaneous regression of metastases from melanoma:review of the literature. Melanoma Res. 2009;19:275–282.
19. Kuriyama S, Mitoro A, Tsujinoue H, et al. Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice. Int J Oncol. 2000;16:979–985.
20. Miyazaki S, Gunji Y, Matsubara H, et al. Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today. 2003;33:39–44.
21. Di Gennaro P, Gerlini G, Urso C, et al. CD4 + FOXP3+ T regulatory cells decrease and CD3 + CD8+ T cells recruitment in TILs from melanoma metastases after electrochemotherapy. Clin Exp Metastasis. 2016;33:787–798.
22. Daud AI, DeConti RC, Andrews S, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol. 2008;26:5896–5903.
23. Teulings HE, Limpens J, Jansen SN, et al. Vitiligo-like depigmentation in patients with stage III–IV melanoma receiving immunotherapy and its association with survival:a systematic review and meta-analysis. J Clin Oncol. 2015;33:773–781.
24. Frandsen SK, Gibot L, Madi M, et al. Calcium electroporation:evidence for differential effects in normal and malignant cell lines, evaluated in a 3D spheroid model. PLoS One. 2015;10:e0144028.
25. Frandsen SK, Gissel H, Hojman P, et al. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012;72:1336–1341.
26. National Institute for Health and Care Excellence (NICE). Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. [Internet]. United Kingdom:National Institute for Health and Excellence; 2013 [cited 2017 Jan 10]. Available from:https://www.nice.org.uk/guidance/ipg446